as 12-20-2024 4:00pm EST
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Founded: | 1944 | Country: | United States |
Employees: | N/A | City: | INDIANAPOLIS |
Market Cap: | 92.9B | IPO Year: | N/A |
Target Price: | $543.07 | AVG Volume (30 days): | 2.0M |
Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 27.42 | EPS Growth: | 9.17 |
52 Week Low/High: | $362.21 - $567.26 | Next Earning Date: | 01-22-2025 |
Revenue: | $174,015,000,000 | Revenue Growth: | 3.20% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | 7.61% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Kendrick Charles Morgan JR | ELV | EVP & President, Commercial | Oct 18 '24 | Sell | $432.14 | 7,417 | $3,205,182.38 | 8,423 |
ELV Breaking Stock News: Dive into ELV Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
20 hours ago
Zacks
a day ago
Morningstar Research
3 days ago
Morningstar Research
4 days ago
Yahoo Finance Video
4 days ago
MT Newswires
4 days ago
Simply Wall St.
5 days ago
Business Wire
10 days ago
The information presented on this page, "ELV Elevance Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.